Attendees at the inaugural Advanced Urologic Cancer Consensus Conference (AUC3) met in Miami, Florida on January 23-24 to agree on optimal diagnostic and management strategies for kidney and bladder cancers. “Tremendous progress has been made…
Angela Cappello, PhD, received a 2024 KCA Trailblazer Award for research on “Drugs resistance mechanisms guided by amino acids catabolism in clear cell renal cell carcinoma (ccRCC).” Dr. Capello is part of the Interdisciplinary Department…
This year, the Kidney Cancer Association made headway on multiple research initiatives across a range of focus areas. Here are our top 10 achievements in 2024. Research Breakthroughs Patient-Centered HRQOL Measures for mRCC – Through…
Several researchers who received funding from the Kidney Cancer Association published exciting new findings in 2024 based on their work. These papers and presentations are the important work of better understanding how kidney cancer works…
Dr. Yuexin Xu received a 2024 Kidney Cancer Association Trailblazer Award for research on “Characterization of tumor endothelial STAB1-mediated Treg recruitment into renal cell carcinoma.” Dr. Xu is a researcher based at Fred Hutchinson Cancer…
Dr. Kaushal Asrani received a 2024 Kidney Cancer Association Trailblazer Award in partnership with Joey’s Wings Foundation for research on “Therapeutic Targeting of EGFR and HER2 in Translocation Renal Cell Carcinoma”. Dr. Asrani is a…
Dr. Laura Bukavina received a 2024 Kidney Cancer Association Trailblazer Award for research on “Assessing the Presence and Impact of Micro- and Nanoplastics Role in Renal Cell Carcinoma”. Dr. Bukavina, a translational surgeon-scientist, is assistant professor…
Dr. Mitchell Hayes received a 2024 Kidney Cancer Association Trailblazer Award in partnership with the Michael and Ina Korek Foundation for research on “Tracing the Seeds of Progression: Spatial Transcriptomic Analysis of Immunoresistant Kidney Cancer”….
Dr. Elizabeth Ellis received a 2024 Kidney Cancer Association Chromophobe RCC Focus Award in partnership with the Chromophobe and Oncocytic Tumor Alliance for research on “Evaluating the Response of Chromophobe Renal Cell Carcinoma to Novel…
We rounded up a few research highlights from the 2024 Congress of the European Society for Medical Oncology (ESMO), held recently in Madrid, Spain. Belzutifan continues to outperform targeted therapy in advanced kidney cancer Belzutifan outperformed targeted…